Pulmonary vascular disease

Pulmonary vascular disease

Direct oral anticoagulants for the treatment of acute venous thromboembolism in patients with cancer: a meta-analysis of randomised controlled trials
Matteo Nicola Dario Di Minno, Walter Ageno, Roberta Lupoli, Giulia Conte, Nick van Es, Harry R. Buller, Francesco Dentali

European Respiratory Journal Sep 2017, 50 (3) 1701097; DOI: 10.1183/13993003.01097-2017
Evaluation of criteria for exercise-induced pulmonary hypertension in patients with resting pulmonary hypertension
Christopher J. Mullin, Steven Hsu, Kaushik Amancherla, Alison Wand, Parker Rhodes, Peter J. Leary, Monica Mukherjee, Rachel L. Damico, Todd M. Kolb, Stephen C. Mathai, Paul M. Hassoun, Ryan J. Tedford

European Respiratory Journal Sep 2017, 50 (3) 1700784; DOI: 10.1183/13993003.00784-2017
Randomised placebo-controlled safety and tolerability trial of FK506 (tacrolimus) for pulmonary arterial hypertension
Edda Spiekerkoetter, Yon K. Sung, Deepti Sudheendra, Valerie Scott, Patricia Del Rosario, Matthew Bill, Francois Haddad, Janel Long-Boyle, Haley Hedlin, Roham T. Zamanian

European Respiratory Journal Sep 2017, 50 (3) 1602449; DOI: 10.1183/13993003.02449-2016
Targeting bone morphogenic protein receptor 2 (BMPR2) signalling to treat pulmonary arterial hypertension
Lewis J. Rubin

European Respiratory Journal Sep 2017, 50 (3) 1701370; DOI: 10.1183/13993003.01370-2017
Inhaled budesonide for acute mountain sickness
Robert Naeije, Erik R. Swenson

European Respiratory Journal Sep 2017, 50 (3) 1701355; DOI: 10.1183/13993003.01355-2017
Inhaled budesonide does not prevent acute mountain sickness after rapid ascent to 4559 m
Marc Moritz Berger, Franziska Macholz, Mahdi Sareban, Peter Schmidt, Sebastian Fried, Daniel Dankl, Josef Niebauer, Peter Bärtsch, Heimo Mairbäurl

European Respiratory Journal Sep 2017, 50 (3) 1700982; DOI: 10.1183/13993003.00982-2017
RESPITE: switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors
Marius M. Hoeper, Gérald Simonneau, Paul A. Corris, Hossein-Ardeschir Ghofrani, James R. Klinger, David Langleben, Robert Naeije, Pavel Jansa, Stephan Rosenkranz, Laura Scelsi, Ekkehard Grünig, Carmine Dario Vizza, MiKyung Chang, Pablo Colorado, Christian Meier, Dennis Busse, Raymond L. Benza

European Respiratory Journal Sep 2017, 50 (3) 1602425; DOI: 10.1183/13993003.02425-2016
Are indexed values better for defining exercise pulmonary hypertension?
Jason Weatherald, Athénaïs Boucly, Edmund Lau, Laurent Godinas, Laurent Savale, Xavier Jaïs, David Montani, Olivier Sitbon, Gérald Simonneau, Marc Humbert, Denis Chemla, Philippe Hervé

European Respiratory Journal Sep 2017, 50 (3) 1700240; DOI: 10.1183/13993003.00240-2017
Challenging the concept of adding more drugs in pulmonary arterial hypertension
Caio J. C. dos Santos Fernandes, Marc Humbert, Rogerio Souza

European Respiratory Journal Sep 2017, 50 (3) 1701527; DOI: 10.1183/13993003.01527-2017
Vascular remodelling in the pulmonary circulation after major lung resection
Nina Rol, Chris Happé, Jeroen A.M. Beliën, Frances S. de Man, Nico Westerhof, Anton Vonk-Noordegraaf, Katrien Grünberg, Harm J. Bogaard

European Respiratory Journal Aug 2017, 50 (2) 1700806; DOI: 10.1183/13993003.00806-2017

Main menu

User menu

Search

Pulmonary vascular disease

Pages

Contact us